Secondary abnormalities of neurotransmitters in infants with neurological disorders

Neurotransmitters are essential in young children for differentiation and neuronal growth of the developing nervous system. We aimed to identify possible factors related to secondary neurotransmitter abnormalities in pediatric patients with neurological disorders. We analyzed cerebrospinal fluid (CSF) and biogenic amine metabolites in 56 infants (33 males, 23 females; mean age 5.8mo [SD 4.1mo] range 1d–1y) with neurological disorders whose aetiology was initially unknown. Patients were classified into three clinical phenotypes: epileptic encephalopathy, severe motor impairment, and non‐specific manifestations. All patients showed normal results for screening of inborn errors of metabolism. We report clinical, neuroimaging, and follow‐up data. Among the patients studied, 10 had low homovanillic acid (HVA) levels and in four patients, 5‐hydroxyindoleacetic acid (5‐HIAA) was also reduced. Patients with neonatal onset had significantly lower levels of HVA than a comparison group. HVA deficiency was also associated with severe motor impairment and the final diagnosis related to neurodegenerative disorders. 5‐HIAA values tended to be decreased in patients with brain cortical atrophy. The possibility of treating patients with L‐Dopa and 5‐hydroxytryptophan, in order to improve their neurological function and maturation, may be considered.

[1]  Rapid-onset dystonia-parkinsonism , 2020, Definitions.

[2]  A. Ormazabal,et al.  PERINATAL ASPHYXIA MAY CAUSE REDUCTION IN CSF DOPAMINE METABOLITE CONCENTRATIONS , 2007, Neurology.

[3]  A. Ormazabal,et al.  HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins , 2005, Journal of Neuroscience Methods.

[4]  H. Lagercrantz,et al.  Development of neurotransmitter systems during critical periods , 2004, Experimental Neurology.

[5]  R. Surtees,et al.  Selective Decrease in Central Nervous System Serotonin Turnover in Children with Dopa-Nonresponsive Dystonia , 2002, Pediatric Research.

[6]  Maria A Oquendo,et al.  Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels , 2001, Biological Psychiatry.

[7]  H. Lagercrantz,et al.  Neurotransmitters and neuromodulators during early human development. , 2001, Early human development.

[8]  N. Blau,et al.  Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. , 2001, American journal of human genetics.

[9]  K. Blennow,et al.  Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters Monoamine metabolites in 120 suicide attempters and 47 controls , 1999, European Neuropsychopharmacology.

[10]  K. Blennow,et al.  Decreased Lumbar Cerebrospinal Fluid Levels of Monoamine Metabolites in Vascular Dementia , 1996, International Psychogeriatrics.

[11]  D. Howells,et al.  Cerebrospinal Fluid Concentrations of Pterins and Metabolites of Serotonin and Dopamine in a Pediatric Reference Population , 1993, Pediatric Research.

[12]  O. Devinsky,et al.  Cerebrospinal Fluid and Serum Levels of DOPA, Catechols, and Monoamine Metabolites in Patients with Epilepsy , 1992, Epilepsia.

[13]  M. Giroud,et al.  5‐Hydroxyindoleacetic Acid and Homovanillic Acid in Cerebrospinal Fluid of Children with Febrile Convulsions , 1990, Epilepsia.

[14]  M. Cavanagh,et al.  Transient expression of neurotransmitters in the developing neocortex , 1988, Trends in Neurosciences.

[15]  J. Jankovic,et al.  Lesch‐nyhan syndrome: A study of motor behavior and cerebrospinal fluid neurotransmitters , 1988, Annals of neurology.

[16]  S. Stahl,et al.  CSF Monoamine Metabolites in Movement Disorders and Normal Aging , 1985 .

[17]  D. Blackwood,et al.  Homovanillic acid and 5‐hydroxyindoleacetic acid in lumbar cerebrospinal fluid in children with afebrile and febrile convulsions , 1981, Neurology.

[18]  N. Holtzman,et al.  A disorder of biogenic amines in dihydropteridine reductase deficiency , 1978, Annals of neurology.

[19]  C. McKean.  The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. , 1972, Brain research.

[20]  G. Erba,et al.  The concentration of homovanillic and 5‐hydroxyindoleacetic acids in ventricular and lumbar CSF , 1972, Neurology.

[21]  K. Lange,et al.  Neurotransmitters in CSF of idiopathic adult-onset dystonia: Reduced 5-HIAA levels as evidence of impaired serotonergic metabolism , 2005, Journal of Neural Transmission.

[22]  R. Wevers,et al.  Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism. , 2003, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[23]  A. Abdel‐Rahman,et al.  phosphatidylcholine-specific phospholipase C elicits mitogen-activated protein kinase phosphorylation in PC12 cells , 2001 .